Literature DB >> 29751127

Temporal trends and patterns in antimicrobial-resistant Gram-negative bacteria implicated in intensive care unit-acquired infections: A cohort-based surveillance study in Istanbul, Turkey.

Bulent Durdu1, Evangelos I Kritsotakis2, Andrew C K Lee3, Perihan Torun4, Ismail N Hakyemez1, Bilge Gultepe5, Turan Aslan1.   

Abstract

OBJECTIVES: This study assessed trends and patterns in antimicrobial-resistant intensive care unit (ICU)-acquired infections caused by Gram-negative bacteria (GNB) in Istanbul, Turkey.
METHODS: Bacterial culture and antimicrobial susceptibility data were collected for all GNB causing nosocomial infections in five adult ICUs of a large university hospital in 2012-2015. Multiresistance patterns were categorised as multidrug-resistant (MDR), extensively drug-resistant (XDR) and pandrug-resistant (PDR). Temporal patterns and trends were assessed using regression analyses.
RESULTS: Of 991 pathogenic GNB recorded, the most frequent were Acinetobacter baumannii (35.3%), Klebsiella spp. (26.7%), Pseudomonas aeruginosa (18.1%) and Escherichia coli (6.7%). The overall infection rate decreased by 41% from 18.4 to 10.9 cases per 1000 patient-days in 2012 compared with 2015 (P<0.001), mostly representing decreases in bloodstream infections and pneumonias by A. baumannii and P. aeruginosa. The XDR proportion in A. baumannii increased from 52.4% in 2012 to 71.7% in 2015, but only one isolate was colistin-resistant. Multiresistance patterns remained stable in Klebsiella, with overall XDR and possible PDR proportions of 14.3% and 1.9%, respectively. A back-to-susceptibility trend was noted for P. aeruginosa in which the non-MDR proportion increased from 53.3% in 2012 to 70.6% in 2015. Moreover, 87.9% of E. coli and 39.5% of Enterobacter isolates were MDR, but none was XDR.
CONCLUSIONS: Antimicrobial resistance patterns in pathogenic GNB continuously change over time and may not reflect single-agent resistance trends. The proportionate amount of antimicrobial-resistant GNB may persist despite overall decreasing infection rates. Timely regional surveillance data are thus imperative for optimal infection control.
Copyright © 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial resistance; Gram-negative bacteria; Intensive care unit; Nosocomial infection; Surveillance; Time trends

Mesh:

Year:  2018        PMID: 29751127     DOI: 10.1016/j.jgar.2018.04.015

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  4 in total

1.  Surveillance study of bloodstream infections, antimicrobial use, and resistance patterns among intensive care unit patients: A retrospective cross-sectional study.

Authors:  Mera A Ababneh; Mohammad Al Domi; Abeer M Rababa'h
Journal:  Int J Crit Illn Inj Sci       Date:  2022-06-24

2.  Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.

Authors:  Hanan H Balkhy; Aiman El-Saed; Majid M Alshamrani; Asim Alsaedi; Wafa Al Nasser; Ayman El Gammal; Sameera M Aljohany; Sara Almunif; Yassen Arabi; Saad Alqahtani; Henry Baffoe Bonnie; Majed Alghoribi; Adel Alothman; Saad A Almohrij
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-30       Impact factor: 4.887

3.  Low-temperature laminar flow ward for the treatment of multidrug resistance Acinetobacter baumannii pneumonia.

Authors:  Zhitao Gong; Jin Li; Hongliang Luo; Daqiang Zhan; Xuanhui Liu; Chuang Gao; Jinhao Huang; Yu Qian; Yiming Song; Wei Quan; Shuo An; Ye Tian; Zhidong Hu; Jian Sun; Hengjie Yuan; Rongcai Jiang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-02       Impact factor: 3.267

4.  A scoping review of registry captured indicators for evaluating quality of critical care in ICU.

Authors:  Issrah Jawad; Sumayyah Rashan; Chathurani Sigera; Jorge Salluh; Arjen M Dondorp; Rashan Haniffa; Abi Beane
Journal:  J Intensive Care       Date:  2021-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.